QS Pharma provides a broad range of contract development/research and clinical/commercial manufacturing services for pharmaceutical and biopharmaceutical companies worldwide. he focus of QS Pharma spans the early development process from the screening and identification of New Chemical Entities (NCEs) to providing preclinical toxicology formulations for early phase work through the development of stable, bioavailable, manufacturable, and registerable dosage forms for use in Clinical trials and providing subsequent Commercial manufacturing for those approvable drug candidates.
Company was acquired by Quotient Clinical
(610) 485 4270Fax:
(610) 485 5933Email:
3 Chelsea Parkway, Suite 305.
Boothwyn PA 19061